The Impact of the Ferric Carboxymaltose on Hemoglobin and Ferritin Levels.

Korur A., Gereklioğlu Ç., Asma S., Aytan P., Tanrikulu F., Solmaz S., ...Daha Fazla

Clinical laboratory, cilt.66, sa.8, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 66 Sayı: 8
  • Basım Tarihi: 2020
  • Doi Numarası: 10.7754/clin.lab.2020.191030
  • Dergi Adı: Clinical laboratory
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Anahtar Kelimeler: iron deficiency, iron treatment, ferric carboxymaltose, IRON-DEFICIENCY, ANEMIA
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background: Anemia is a frequent disorder worldwide. Iron deficiency anemia (IDA) is the most common form of anemia. Although oral iron is the first choice for treatment, the efficacy of oral iron preparations may be limited. Ferric carboxymaltose (FCM) is a novel parenteral iron preparation which can rapidly replenish iron stores. The aim of the present study is to investigate the impact of FCM dose on hemoglobin (Hb) and ferritin levels and the frequency of hypersensitivity reactions.